Published in Int J Womens Health on July 25, 2014
H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet (2009) 12.32
Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med (2008) 7.79
Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ (2009) 6.13
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA (2010) 5.94
Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med (2009) 5.35
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2004) 5.00
Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol (1998) 4.29
Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol (1959) 3.22
Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ (2011) 3.20
Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ (2007) 3.05
Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol (2010) 2.69
2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia. Clin Infect Dis (2010) 2.60
Novel influenza A (H1N1) virus infections in three pregnant women - United States, April-May 2009. MMWR Morb Mortal Wkly Rep (2009) 2.50
Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med (2010) 2.47
Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. CMAJ (2010) 2.36
Natality decline and miscarriages associated with the 1918 influenza pandemic: the Scandinavian and United States experiences. J Infect Dis (2011) 2.33
Neuraminidase inhibitors for preventing and treating influenza in children. Cochrane Database Syst Rev (2007) 2.15
Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG (2000) 1.88
Hospitalizations with respiratory illness among pregnant women during influenza season. Obstet Gynecol (2006) 1.88
Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med (2013) 1.86
Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis (2010) 1.84
Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med (2011) 1.82
2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol (2011) 1.69
Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis (1993) 1.65
Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ (2012) 1.65
Influenza immunization in pregnancy--antibody responses in mothers and infants. N Engl J Med (2010) 1.55
Pandemic influenza A H1N1 2009 infection versus vaccination: a cohort study comparing immune responses in pregnancy. PLoS One (2012) 1.55
Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J Infect Dis (1979) 1.55
Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol (2011) 1.52
Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol (2004) 1.52
Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant. Health Technol Assess (2010) 1.49
Influenza-attributed hospitalization rates among pregnant women in Canada 1994-2000. J Obstet Gynaecol Can (2007) 1.45
Seasonal influenza and 2009 H1N1 influenza vaccination coverage among pregnant women--10 states, 2009-10 influenza season. MMWR Morb Mortal Wkly Rep (2010) 1.44
Maternal and infant outcomes among severely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1)--United States, April 2009-August 2010. MMWR Morb Mortal Wkly Rep (2011) 1.39
H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. Am J Public Health (2012) 1.36
Pharmacokinetics of oseltamivir among pregnant and nonpregnant women. Am J Obstet Gynecol (2011) 1.36
Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int J Epidemiol (1973) 1.34
Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ (2009) 1.32
Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. J Infect Dis (2011) 1.28
Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009. Am J Obstet Gynecol (2010) 1.25
Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol (2011) 1.25
Pregnant women's knowledge of influenza and the use and safety of the influenza vaccine during pregnancy. J Obstet Gynaecol Can (2009) 1.22
Pharmacokinetics of oseltamivir according to trimester of pregnancy. Am J Obstet Gynecol (2011) 1.22
Influenza vaccination coverage among pregnant women --- United States, 2010-11 influenza season. MMWR Morb Mortal Wkly Rep (2011) 1.22
Behaviors and perceptions regarding seasonal and H1N1 influenza vaccination during pregnancy. Am J Obstet Gynecol (2011) 1.21
Neonatal outcomes after antenatal influenza immunization during the 2009 H1N1 influenza pandemic: impact on preterm birth, birth weight, and small for gestational age birth. Clin Infect Dis (2013) 1.20
Vaccination and perinatal infection prevention practices among obstetrician-gynecologists. Obstet Gynecol (2003) 1.19
The use of antiviral drugs for influenza: Guidance for practitioners 2012/2013. Can J Infect Dis Med Microbiol (2012) 1.19
Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons. Clin Infect Dis (2013) 1.18
Effect of respiratory hospitalization during pregnancy on infant outcomes. Am J Obstet Gynecol (2011) 1.18
Novel pandemic A (H1N1) influenza vaccination among pregnant women: motivators and barriers. Am J Obstet Gynecol (2011) 1.17
Perinatal and maternal outcomes in critically ill obstetrics patients with pandemic H1N1 Influenza A. J Obstet Gynaecol Can (2010) 1.17
Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women. J Clin Microbiol (1979) 1.15
Correlates of seasonal influenza vaccine coverage among pregnant women in Georgia and Rhode Island. Obstet Gynecol (2010) 1.13
Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic. Am J Obstet Gynecol (2011) 1.09
Improving influenza vaccination rates in pregnancy through text messaging: a randomized controlled trial. Obstet Gynecol (2013) 1.08
Influenza vaccination in pregnancy: practices among obstetrician-gynecologists--United States, 2003-04 influenza season. MMWR Morb Mortal Wkly Rep (2005) 1.07
Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications. Obstet Gynecol (2010) 1.07
Potential impact of pandemic influenza on blood safety and availability. Transfus Med Rev (2006) 1.06
Predictors of seasonal influenza vaccination during pregnancy. Obstet Gynecol (2013) 1.04
A cross-sectional study of maternity care providers' and women's knowledge, attitudes, and behaviours towards influenza vaccination during pregnancy. J Obstet Gynaecol Can (2008) 1.03
Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am J Obstet Gynecol (2012) 1.02
The obstetrician-gynecologist's role in vaccine-preventable diseases and immunization. Obstet Gynecol (2000) 1.02
Obstetric health care workers' attitudes and beliefs regarding influenza vaccination in pregnancy. Obstet Gynecol (2009) 1.00
Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial. Ann Intern Med (2011) 1.00
Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study. Vaccine (2011) 0.99
Immunogenicity of trivalent inactivated influenza vaccination received during pregnancy or postpartum. Obstet Gynecol (2012) 0.99
The association between influenza vaccine in pregnancy and adverse neonatal outcomes. J Obstet Gynaecol Can (2012) 0.96
Impact of patient education on knowledge of influenza and vaccine recommendations among pregnant women. J Obstet Gynaecol Can (2010) 0.95
Transplacental antibody transfer following maternal immunization with a pandemic 2009 influenza A(H1N1) MF59-adjuvanted vaccine. JAMA (2010) 0.95
Predictors of H1N1 vaccination in pregnancy. Am J Obstet Gynecol (2011) 0.94
2009 H1N1 vaccination by pregnant women during the 2009-10 H1N1 influenza pandemic. Am J Obstet Gynecol (2011) 0.94
Risk perceptions, worry, or distrust: what drives pregnant women's decisions to accept the H1N1 vaccine? Matern Child Health J (2011) 0.91
Neonatal characteristics and outcomes of pregnancies complicated by influenza infection during the 2009 pandemic. Am J Obstet Gynecol (2011) 0.90
Non-adjuvanted 2009 influenza A (H1N1)v vaccine in pregnant women: the results of a French prospective descriptive study. Vaccine (2011) 0.90
Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. Br J Clin Pharmacol (2012) 0.89
Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women. Clin Infect Dis (2013) 0.89
Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol (2006) 0.87
Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials. J Antimicrob Chemother (2010) 0.87
Pregnancy modifies the antibody response to trivalent influenza immunization. J Infect Dis (2012) 0.87
Outcomes of infants exposed to oseltamivir or zanamivir in utero during pandemic (H1N1) 2009. Am J Obstet Gynecol (2013) 0.84
Hospitalization of pregnant women with pandemic A(H1N1) 2009 influenza in Canada. Epidemiol Infect (2011) 0.83
Birth outcomes among women exposed to neuraminidase inhibitors during pregnancy. Pharmacoepidemiol Drug Saf (2011) 0.82
Infant outcomes among pregnant women who used oseltamivir for treatment of influenza during the H1N1 epidemic. Am J Obstet Gynecol (2013) 0.79
New adjuvanted vaccines in pregnancy: what is known about their safety? Expert Rev Vaccines (2010) 0.77